Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    Open Studies | "Gastrointestinal Stromal Tumors"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Gastrointestinal Stromal Tumors"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001
Condition: Gastrointestinal Stromal Tumor
Interventions: Genetic: mutation analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis
2 Recruiting Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Intervention: Procedure: surgery or biopsy
3 Recruiting A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: sunitinib malate dose escalation;   Drug: sunitinib malate
4 Not yet recruiting A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: BBI503
5 Not yet recruiting the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor
Condition: Gastrointestinal Stromal Tumor
Interventions: Procedure: Laparoscopic endoscopy combined surgery;   Procedure: laparoscopic and endoscopic cooperative surgery;   Procedure: Single-arch laparoscopic and endoscopic cooperative surgery
6 Not yet recruiting Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
Condition: Gastrointestinal Stromal Tumor
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
7 Recruiting A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST)
Condition: Gastrointestinal Stromal Tumour
Interventions: Drug: Regorafenib;   Drug: imatinib
8 Recruiting Efficacy and Safety of PD-0332991 in Patients With Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
Condition: Advanced Gastrointestinal Stromal Tumors
Intervention: Drug: PD-0332991 will be administrated orally, formulated as gelatin capsules of 100 mg and 25 mg respectively.
9 Not yet recruiting A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors
Condition: Gastrointestinal Stromal Tumor
Intervention: Biological: Intuvax (suspension for intratumoral injection)
10 Not yet recruiting Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Imatinib;   Other: Surveillance
11 Not yet recruiting SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: Pazopanib;   Drug: Trametinib
12 Recruiting MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Gastrointestinal Stromal Tumor (GIST)
Interventions: Drug: MEK162;   Drug: Imatinib Mesylate (Gleevec®; STI571; NSC #716051);   Other: Blood draws;   Procedure: biopsy
13 Recruiting Circulating Cell-free Tumor DNA in the Plasma of Patients With Gastrointestinal Stromal Tumors (GIST)
Condition: Gastrointestinal Stromal Tumor (GIST)
Intervention: Other: Vena puncture for blood collection
14 Recruiting BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
Condition: Advanced Gastrointestinal Stromal Tumor (GIST)
Interventions: Drug: BGJ398;   Drug: Imatinib Mesylate
15 Recruiting Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Sunitinib;   Drug: Regorafenib
16 Recruiting Regorafenib Post-marketing Surveillance in Japan
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Regorafenib (Stivarga, BAY73-4506)
17 Recruiting A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AUY922
18 Recruiting PLX9486 as a Single Agent and in Combination With PLX3397 in Patients With Advanced Solid Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: PLX9486;   Drug: PLX3397
19 Recruiting A Trial of Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Paclitaxel
20 Recruiting GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Condition: Gastro-intestinal Stromal Tumor
Interventions: Procedure: Vena puncture for blood collection;   Procedure: Tumor biopsy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.